CTX310 Lipid Disorder: Phase 1 Trial Shows Prom...

By HEOR Staff Writer

November 10, 2025

CTX310 Breakthrough in Lipid Disorder Treatment CTX310 is a significant advancement as the first-in-human Phase 1 trial of this
Transforming Healthcare with the Gene Therapy Access Model
Bupa Launches Whole Genome Sequencing Pilot in UK
A Value Framework for Next-Generation Sequencing in Europe: Access to Precisi...
Understanding the Cost and Funding of Gene Therapies
Abu Dhabi Strategic Healthcare Partnerships: Global Collaborations
Genome-Wide Sequencing in Diagnosing Rare Diseases: Clinical and Economic Imp...
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Policy of Innovative Health Technology: Biobanks in Abu Dhabi
The Crucial Role of Pharmacogenetic testing in Thiopurine Therapy
Precision Medicine: A New Paradigm in Healthcare
The Cost-Effectiveness of Celiac Disease Screening: An Analysis
A Glimpse into the PBAC December 2023 Meeting Outcomes